Shares of Concert Pharmaceuticals, Inc. CNCE were up 17.4% last week on its proposed acquisition by India-based Sun Pharmaceutical Industries Ltd. On Jan 19, Concert Pharmaceuticals announced a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results